UK Festival of Robotics concludes with major report launch, plus announcement of UK-RAS Network Award winners for research excellence and community contribution
5th July 2021 12:02 am 2nd July 2021 11:14 am
Artificial intelligence is being used to help detect early signs of oesophageal cancer, a disease with a five-year survival rate of under 20 per cent.
Image: UCL
The first procedure in the world using the so-called CADU AI technology was performed at University College Hospital by UCLH consultant gastroenterologist Dr Rehan Haidry.
CADU achieved regulatory approval at the start of 2021 making it the first medical device using AI for oesophageal cancer to be CE and UKCA approved for use on patients. It has been developed in collaboration with UCL scientists, including Dr Haidry, and Odin Vision, a spinout formed out of the research and innovation work at the UCL Wellcome / EPSRC Centre for Interventional and Surgical Sciences.